Skyline Asset Management LP lowered its position in shares of TriMas Corp (NASDAQ:TRS) by 14.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 416,900 shares of the industrial products company’s stock after selling 68,200 shares during the period. TriMas accounts for 2.4% of Skyline Asset Management LP’s portfolio, making the stock its 3rd biggest holding. Skyline Asset Management LP owned about 0.91% of TriMas worth $12,911,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the company. Mawer Investment Management Ltd. raised its holdings in TriMas by 35.3% during the 1st quarter. Mawer Investment Management Ltd. now owns 804,441 shares of the industrial products company’s stock worth $24,318,000 after buying an additional 209,915 shares during the period. American Century Companies Inc. boosted its position in TriMas by 22.6% during the fourth quarter. American Century Companies Inc. now owns 165,075 shares of the industrial products company’s stock worth $4,505,000 after purchasing an additional 30,438 shares during the period. SG Americas Securities LLC bought a new stake in TriMas during the first quarter worth approximately $299,000. Geode Capital Management LLC boosted its position in TriMas by 8.8% during the fourth quarter. Geode Capital Management LLC now owns 524,716 shares of the industrial products company’s stock worth $14,319,000 after purchasing an additional 42,250 shares during the period. Finally, BlackRock Inc. boosted its position in TriMas by 2.6% during the fourth quarter. BlackRock Inc. now owns 3,217,701 shares of the industrial products company’s stock worth $87,810,000 after purchasing an additional 81,685 shares during the period. Institutional investors and hedge funds own 97.73% of the company’s stock.
Separately, BidaskClub raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, June 20th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. TriMas currently has a consensus rating of “Hold” and a consensus price target of $34.50.
TriMas stock traded up $0.08 during midday trading on Friday, reaching $30.87. The stock had a trading volume of 5,499 shares, compared to its average volume of 131,239. The company’s fifty day moving average is $30.32. TriMas Corp has a 1-year low of $25.18 and a 1-year high of $33.45. The stock has a market capitalization of $1.43 billion, a PE ratio of 17.60, a P/E/G ratio of 3.29 and a beta of 1.50. The company has a quick ratio of 1.61, a current ratio of 2.86 and a debt-to-equity ratio of 0.46.
TriMas (NASDAQ:TRS) last released its earnings results on Tuesday, April 30th. The industrial products company reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.04. TriMas had a return on equity of 13.54% and a net margin of 8.86%. The firm had revenue of $221.29 million during the quarter, compared to the consensus estimate of $225.12 million. During the same period in the prior year, the company posted $0.41 EPS. The company’s revenue was up 1.9% compared to the same quarter last year. As a group, equities analysts anticipate that TriMas Corp will post 1.91 EPS for the current year.
In other news, insider Thomas A. Amato sold 14,991 shares of the firm’s stock in a transaction on Friday, May 17th. The stock was sold at an average price of $30.64, for a total value of $459,324.24. Following the completion of the transaction, the insider now directly owns 117,713 shares of the company’s stock, valued at $3,606,726.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Eugene A. Miller sold 10,000 shares of TriMas stock in a transaction on Monday, May 20th. The shares were sold at an average price of $30.01, for a total value of $300,100.00. Following the sale, the director now directly owns 99,425 shares of the company’s stock, valued at approximately $2,983,744.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 54,383 shares of company stock worth $1,649,389. 1.30% of the stock is owned by corporate insiders.
TriMas Company Profile
TriMas Corporation manufactures and sells products for consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs, manufactures, and sells specialty closure products, including steel and plastic drum closures, plastic pail dispensers and plugs, and plastic enclosures; specialty dispensing products, such as foamers, lotion pumps, fine mist sprayers, airless dispensers, and other packaging solutions for the cosmetic, personal care, and household product markets; and specialty plastic closures for bottles and jars in the food and beverage markets under the Rieke name.
Featured Article: The components of the Stochastic Momentum Index
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.